Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.5%

2 terminated/withdrawn out of 133 trials

Success Rate

97.3%

+10.8% vs industry average

Late-Stage Pipeline

29%

38 trials in Phase 3/4

Results Transparency

8%

6 of 71 completed trials have results

Key Signals

11 recruiting6 with results

Enrollment Performance

Analytics

N/A
43(45.3%)
Phase 4
26(27.4%)
Phase 2
12(12.6%)
Phase 3
12(12.6%)
Phase 1
2(2.1%)
95Total
N/A(43)
Phase 4(26)
Phase 2(12)
Phase 3(12)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (133)

Showing 20 of 133 trials
NCT07318428Not ApplicableCompleted

AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and Glaucoma

Role: collaborator

NCT06388720Phase 2Recruiting

The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy

Role: collaborator

NCT07455552Not ApplicableCompleted

Smartphone-based Telerehabilitation Versus Home-based Inspiratory Muscle Training After Lung Resection in High-risk Patients

Role: lead

NCT07497867Recruiting

Long-term Prospective Study of Korean CADASIL Patients

Role: collaborator

NCT06805123Not ApplicableRecruiting

Early Feeding Versus Delayed Feeding After Colorectal Endoscopic Submucosal Dissection

Role: lead

NCT07470242Not ApplicableCompleted

Povidone-Iodine Nasal Irrigation After Surgery for Chronic Rhinosinusitis

Role: lead

NCT06301295Not ApplicableActive Not Recruiting

Feasibility of Targeted Bronchial Washing for Molecular Testing by Next Generation Sequencing in Early-stage Lung Cancer

Role: lead

NCT06086665Completed

The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer

Role: collaborator

NCT07073365Phase 2Recruiting

Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor Therapy (BOOST Trial)

Role: lead

NCT06984952Not ApplicableRecruiting

Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive Gastrectomy

Role: collaborator

NCT05517083Not ApplicableCompleted

Feasibility of Intratumoral Washing Fluid for Detecting EGFR Mutations in Lung Cancer

Role: lead

NCT06141005Not ApplicableCompleted

Feasibility of Bronchial Washing Fluid for Molecular Testing With Next Generation Sequencing in Lung Cancer

Role: lead

NCT07122999Not ApplicableCompleted

Autoinflation as a Eustachian Tube Rehabilitation

Role: lead

NCT07072780Not ApplicableCompleted

Effectiveness of a Novel Low-level Laser Therapy Protocol in Managing Breast Cancer-Related Lymphedema

Role: lead

NCT04010955Active Not Recruiting

Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)

Role: collaborator

NCT05435885Not ApplicableCompleted

Postoperative Telerehabilitation in Older Adults

Role: lead

NCT05046093Not ApplicableCompleted

Clinical Outcomes of Cryobiopsy for Peripheral Pulmonary Lesions - A Prospective Pilot Study

Role: lead

NCT06878495Not ApplicableNot Yet Recruiting

Efficacy and Safety of Discontinuing 5-ASA in Patients With Inflammatory Bowel Disease

Role: lead

NCT05255588Completed

A Stool DNA-based SDC2 Methylation Test for the Early Detection of Colorectal Cancer

Role: collaborator

NCT01518556Phase 1Completed

Safety and Efficacy Study of Idarubicin Dose Intensification to Treat Acute Myeloid Leukemia

Role: collaborator